NIH Center for Human Immunology, Inflammation, and Autoimmunity Scientific Advisory Board

The CHI Scientific Advisory Boards (SAB) is composed of internationally recognized scientists. The membership of the Scientific Advisory Board reflects the NIH’s research spectrum and are appointed by the Chair of the SAB after consultation with Scientific Directors (SD) from participating institutes. In justified cases, the Scientific Advisory Board – in agreement SD may enlist additional ad hoc experts.

A Bellwether for COVID-19

Publish or Event Date
Research Institution
Harvard Medical School
Short Title
A Bellwether for COVID-19
Content Coordinator

Snail Fever Vaccine Reaches First Human Clinical Trial

Good News on Blocking a Virus Considered A Global Threat

Latest COVID Treatment Study Finds Superior Treatment

Brain Fog after COVID-19 Has Similarities to “Chemo Brain,” Stanford-Led Study Finds

Vaccine Targeting Mosquito-Borne Viruses Safely Prompts Immune Response in Clinical Trial

Jeffrey Glenn Receives $69 Million to Start Antiviral Drug-Discovery Center at Stanford

Researchers Advance Development of Potential Epstein-Barr Virus Vaccines

Pitt Study Links Racism to Worse Asthma Outcomes

Publish or Event Date
Research Institution
University of Pittsburgh
Short Title
Pitt Study Links Racism to Worse Asthma Outcomes
Content Coordinator